E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression.

The mTOR complex 1 (mTORC1) is an essential metabolic hub that coordinates cellular metabolism with the availability of nutrients, including amino acids. Sestrin2 has been identified as a cytosolic leucine sensor that transmits leucine status signals to mTORC1. In this study, we identify an E3 ubiquitin ligase RING finger protein ...
167 (RNF167) and a deubiquitinase STAMBPL1 that function in concert to control the polyubiquitination level of Sestrin2 in response to leucine availability. Ubiquitination of Sestrin2 promotes its interaction with GATOR2 and inhibits mTORC1 signaling. Bioinformatic analysis reveals decreased RNF167 expression and increased STAMBPL1 expression in gastric and colorectal tumors. Knockout of STAMBPL1 or correction of the heterozygous STAMBPL1 mutation in a human colon cancer cell line suppresses xenograft tumor growth. Lastly, a cell-permeable peptide that blocks the STAMBPL1-Sestrin2 interaction inhibits mTORC1 and provides a potential option for cancer therapy.
Mesh Terms:
Animals, Caco-2 Cells, Cell Proliferation, Colorectal Neoplasms, Disease Progression, Gene Expression Regulation, Neoplastic, HCT116 Cells, HEK293 Cells, Humans, Leucine, Mechanistic Target of Rapamycin Complex 1, Mice, Inbred BALB C, Mice, Nude, Mutation, Nuclear Proteins, Peptide Hydrolases, Signal Transduction, Stomach Neoplasms, TOR Serine-Threonine Kinases, Tumor Burden, Ubiquitin-Protein Ligases, Ubiquitination
Mol Cell
Date: Dec. 17, 2021
Download Curated Data For This Publication
236681
Switch View:
  • Interactions 11